• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Apricus Biosciences, Inc. (APRI)

    -NasdaqCM
    1.14 Down 0.03(2.56%) Feb 12, 3:59PM EST
    Prev Close:1.17
    Open:1.16
    Bid:N/A
    Ask:1.69 x 600
    1y Target Est:3.05
    Beta:0.504289
    Earnings Date:Mar 14 - Mar 18 (Est.)
    Day's Range:1.11 - 1.18
    52wk Range:0.78 - 2.75
    Volume:118,682
    Avg Vol (3m):180,250
    Market Cap:60.35M
    P/E (ttm):N/A
    EPS (ttm):-0.71
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for APRI

    Comparison

    Symbol% ChgMkt Cap
    APRIDown 2.56%60.35M
    ADMPUp 4.78%61.79M
    PFEUp 0.79%181.25B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.33
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.45
    Quarterly EPS Est (Dec-15) :-0.11
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Apricus Biosciences, Inc. engages in developing and commercializing products and product candidates in the areas of urology and rheumatology in the United States, Canada, Europe, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback